Sichuan Hebang Biotechnology Co Ltd Cash Flow Reinvestment Rate
Sichuan Hebang Biotechnology Co Ltd cash flow reinvestment rate. Sichuan Hebang Biotechnology Co Ltd (603077) has a Cash Flow Reinvestment Rate of 1.21x as of September 2025, reinvesting CN¥200.76 Million (capex CN¥200.76 Million ) from operating cash flow of CN¥165.40 Million. See Sichuan Hebang Biotechnology Co Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Sichuan Hebang Biotechnology Co Ltd (2009–2025)
Cash flow reinvestment rate of Sichuan Hebang Biotechnology Co Ltd from 2009 to 2025. Historical reinvestment intensity for Sichuan Hebang Biotechnology Co Ltd across 16 annual periods. Explore Sichuan Hebang Biotechnology Co Ltd (603077) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Sichuan Hebang Biotechnology Co Ltd Cash Flow Reinvestment Rate by Year (2009–2025)
Sichuan Hebang Biotechnology Co Ltd cash flow reinvestment rate by year from 2009 to 2025. Year-by-year capital reinvestment analysis for Sichuan Hebang Biotechnology Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Sichuan Hebang Biotechnology Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.19x | CN¥1.28 Billion | CN¥1.08 Billion | CN¥1.26 Billion | ▼ -59.5% |
| 2024 | 2.93x | CN¥1.37 Billion | CN¥467.93 Million | CN¥1.12 Billion | ▼ -32.7% |
| 2023 | 4.35x | CN¥873.36 Million | CN¥200.76 Million | CN¥828.74 Million | ▲ +1057.3% |
| 2022 | 0.38x | CN¥993.99 Million | CN¥2.64 Billion | CN¥936.18 Million | ▼ -31.4% |
| 2021 | 0.55x | CN¥1.75 Billion | CN¥3.20 Billion | CN¥1.74 Billion | ▼ -20.2% |
| 2020 | 0.69x | CN¥253.10 Million | CN¥368.85 Million | CN¥197.09 Million | ▼ -84.4% |
| 2019 | 4.41x | CN¥717.85 Million | CN¥162.92 Million | CN¥662.54 Million | ▲ +1034.8% |
| 2018 | 0.39x | CN¥366.69 Million | CN¥944.39 Million | CN¥363.57 Million | ▼ -96.1% |
| 2017 | 9.97x | CN¥1.76 Billion | CN¥176.94 Million | CN¥508.53 Million | ▲ +159.4% |
| 2016 | 3.84x | CN¥2.21 Billion | CN¥575.26 Million | CN¥677.45 Million | ▼ -35.2% |
| 2015 | 5.93x | CN¥2.66 Billion | CN¥449.20 Million | CN¥1.13 Billion | ▲ +69.4% |
| 2014 | 3.50x | CN¥716.77 Million | CN¥204.67 Million | CN¥716.77 Million | ▲ +72.6% |
| 2012 | 2.03x | CN¥273.83 Million | CN¥134.96 Million | CN¥273.83 Million | ▲ +224.8% |
| 2011 | 0.62x | CN¥345.17 Million | CN¥552.56 Million | CN¥345.17 Million | ▼ -63.8% |
| 2010 | 1.73x | CN¥571.00 Million | CN¥330.77 Million | CN¥571.00 Million | ▼ -86.0% |
| 2009 | 12.30x | CN¥848.53 Million | CN¥68.97 Million | CN¥848.53 Million | — |